Pfizer Inc. said it agreed to buy the rest of Biohaven Pharmaceutical Holding Co. for about $11.6 billion, giving the New York drugmaker full ownership of the Nurtec ODT migraine franchise. Pfizer said it would pay $148...
Pharmaceutical
Biocon Biologics may close $3.34 billion Viatris deal in Q1
Biocon Biologics said it can close the transaction of $3.34 billion Viatris’ biosimilar business acquisition by as early as this quarter if it gets a nod from regulatory agencies. Kiran Mazumdar-Shaw, chairperson...
U.S. FTC approves Hikma deal for Custopharm with conditions
Generic drugmaker Hikma Pharmaceuticals has won U.S. antitrust approval to buy Custopharm, Inc on condition that it divest an injectable steroid, the U.S. Federal Trade Commission said on Tuesday. Hikma, which makes...
Asahi Songwon Colors enters API biz via Atlas Life Sciences acquisition
Ahmedabad-based pigments major Asahi Songwon Colours Limited on Monday announced its foray into active pharmaceutical ingredient (API) manufacturing with the acquisition of Atlas Life Sciences Private Limited. A leading...
CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others
The Competition Commission of India (CCI) has approved the acquisition of a minority stake of BDR Pharmaceuticals International (BDR) by Multiples Private Equity Fund III and other investors. Apart from Multiples, the...
Ril Weighs Bid For Walgreens Boots Alliance
Billionaire Mukesh Ambani’s Reliance Industries Ltd (RIL) is weighing a possible bid for Walgreens Boots Alliance Inc.’s global drugstore unit, according to people familiar with the matter. RIL is in early stages of...
GSK to buy Sierra Oncology amid pressure to boost drug pipeline
Britain’s GlaxoSmithKline sought to bolster its cancer business on Wednesday by agreeing a $1.9 billion deal to buy U.S. drug developer Sierra Oncology, the latest move to fend off pressure from activist...
Torrent, JB Chemicals in final race to acquire Curatio Healthcare
Torrent Pharmaceuticals and KKR-controlled JB Chemicals are among the final contenders to acquire Chennai-based Curatio Healthcare for about ₹2,500 crore in what could be the continuation of M&A deals in the pharma...
Lupin completes acquisition of portfolio of brands from Anglo-French Drugs & Industries
Drug maker Lupin said it has completed the acquisition of a portfolio of brands from Anglo-French Drugs & Industries Limited (AFDIL) and its associates. The acquisition will strengthen the company’s India...
Pfizer boosts respiratory drug portfolio with ReViral purchase
Pfizer Inc said on Thursday it would buy privately-held ReViral Ltd in a deal worth as much as $525 million including milestone payments, to gain access to experimental drugs against the respiratory syncytial virus...
Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 crore
Suven Pharmaceuticals on Tuesday said its Board has approved the acquisition of Hyderabad-based formulations manufacturer Casper Pharma Private Limited (CPPL) for Rs 155 crore. Suven will purchase100% of share capital...
Bharat Serums and Vaccines acquires key women health brand Tidilan from Jagdale Industries
Private equity firm Advent-backed Bharat Serums and Vaccines (BSV) on Tuesday said it has acquired Tidilan (isoxsuprine hydrochloride), a leading brand in women’s health from Bengaluru-based Jagdale Industries. BSV...